Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 38 | 2020 | 1526 | 2.720 |
Why?
|
| Urinary Bladder Neoplasms | 10 | 2021 | 545 | 1.940 |
Why?
|
| Quality of Life | 24 | 2021 | 1932 | 1.630 |
Why?
|
| Sexual and Gender Minorities | 5 | 2021 | 60 | 1.550 |
Why?
|
| Erectile Dysfunction | 9 | 2016 | 180 | 1.340 |
Why?
|
| Homosexuality, Male | 6 | 2021 | 62 | 1.250 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 657 | 0.920 |
Why?
|
| Sexual Dysfunction, Physiological | 5 | 2016 | 79 | 0.910 |
Why?
|
| Patient Education as Topic | 7 | 2016 | 453 | 0.870 |
Why?
|
| Health Personnel | 3 | 2020 | 493 | 0.860 |
Why?
|
| Sexual Partners | 5 | 2016 | 85 | 0.790 |
Why?
|
| Health Status | 6 | 2016 | 375 | 0.750 |
Why?
|
| Cancer Survivors | 2 | 2020 | 199 | 0.700 |
Why?
|
| Survivorship | 1 | 2020 | 36 | 0.690 |
Why?
|
| Nurses | 1 | 2021 | 64 | 0.690 |
Why?
|
| Prostatectomy | 14 | 2016 | 332 | 0.680 |
Why?
|
| Bisexuality | 3 | 2016 | 15 | 0.670 |
Why?
|
| Patient Care Planning | 1 | 2020 | 121 | 0.660 |
Why?
|
| Internship, Nonmedical | 1 | 2018 | 1 | 0.640 |
Why?
|
| Sexual Dysfunctions, Psychological | 4 | 2013 | 41 | 0.610 |
Why?
|
| Watchful Waiting | 3 | 2015 | 68 | 0.590 |
Why?
|
| Physician Assistants | 1 | 2018 | 61 | 0.590 |
Why?
|
| Health Facilities | 1 | 2018 | 58 | 0.570 |
Why?
|
| Suburban Population | 1 | 2017 | 5 | 0.570 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 420 | 0.570 |
Why?
|
| Anxiety | 7 | 2018 | 961 | 0.540 |
Why?
|
| Veterans | 6 | 2018 | 1735 | 0.530 |
Why?
|
| Interpersonal Relations | 7 | 2018 | 227 | 0.520 |
Why?
|
| Resistance Training | 3 | 2025 | 32 | 0.520 |
Why?
|
| Urban Population | 1 | 2017 | 220 | 0.510 |
Why?
|
| Primary Health Care | 3 | 2018 | 752 | 0.510 |
Why?
|
| Male | 67 | 2025 | 60285 | 0.490 |
Why?
|
| Rural Population | 1 | 2017 | 249 | 0.480 |
Why?
|
| Sexology | 1 | 2014 | 3 | 0.470 |
Why?
|
| Middle Aged | 41 | 2020 | 26075 | 0.460 |
Why?
|
| Perception | 2 | 2012 | 220 | 0.440 |
Why?
|
| Cystectomy | 2 | 2016 | 153 | 0.420 |
Why?
|
| Culture | 1 | 2012 | 66 | 0.390 |
Why?
|
| Aged | 36 | 2020 | 19174 | 0.380 |
Why?
|
| Surveys and Questionnaires | 14 | 2018 | 3680 | 0.370 |
Why?
|
| Decision Making | 3 | 2011 | 652 | 0.370 |
Why?
|
| Humans | 74 | 2025 | 123311 | 0.370 |
Why?
|
| Health Surveys | 1 | 2012 | 243 | 0.360 |
Why?
|
| Urinary Diversion | 2 | 2016 | 42 | 0.340 |
Why?
|
| Muscle, Skeletal | 3 | 2025 | 939 | 0.340 |
Why?
|
| Muscle Strength | 3 | 2025 | 75 | 0.340 |
Why?
|
| Social Support | 5 | 2016 | 345 | 0.330 |
Why?
|
| Health Behavior | 1 | 2012 | 382 | 0.320 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2007 | 1118 | 0.310 |
Why?
|
| Mental Disorders | 4 | 2012 | 826 | 0.310 |
Why?
|
| Needs Assessment | 2 | 2011 | 173 | 0.310 |
Why?
|
| Depression | 9 | 2018 | 1228 | 0.310 |
Why?
|
| Life Style | 3 | 2012 | 404 | 0.300 |
Why?
|
| Patient Admission | 1 | 2009 | 184 | 0.290 |
Why?
|
| Self Concept | 2 | 2016 | 157 | 0.280 |
Why?
|
| Neoplasm Staging | 6 | 2013 | 1213 | 0.270 |
Why?
|
| Isometric Contraction | 1 | 2025 | 22 | 0.240 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 625 | 0.240 |
Why?
|
| Patient Discharge | 1 | 2009 | 491 | 0.240 |
Why?
|
| Electromyography | 1 | 2025 | 164 | 0.230 |
Why?
|
| Prostate-Specific Antigen | 7 | 2008 | 256 | 0.230 |
Why?
|
| Sexual Behavior | 6 | 2021 | 243 | 0.230 |
Why?
|
| Adult | 20 | 2025 | 29087 | 0.220 |
Why?
|
| Mental Health | 1 | 2006 | 347 | 0.220 |
Why?
|
| Impotence, Vasculogenic | 1 | 2003 | 10 | 0.210 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 458 | 0.210 |
Why?
|
| Adaptation, Psychological | 5 | 2016 | 461 | 0.210 |
Why?
|
| Afghan Campaign 2001- | 2 | 2013 | 117 | 0.200 |
Why?
|
| Iraq War, 2003-2011 | 2 | 2013 | 126 | 0.200 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 478 | 0.200 |
Why?
|
| Diabetes Mellitus | 3 | 2006 | 850 | 0.200 |
Why?
|
| Fear | 3 | 2015 | 201 | 0.190 |
Why?
|
| United States | 11 | 2018 | 10667 | 0.190 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 2852 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 3081 | 0.190 |
Why?
|
| Insurance Coverage | 3 | 2008 | 121 | 0.190 |
Why?
|
| Self-Help Groups | 2 | 2013 | 17 | 0.190 |
Why?
|
| Social Workers | 1 | 2021 | 6 | 0.180 |
Why?
|
| Health Care Surveys | 2 | 2020 | 284 | 0.180 |
Why?
|
| Follow-Up Studies | 10 | 2014 | 5050 | 0.180 |
Why?
|
| Female | 17 | 2025 | 65618 | 0.180 |
Why?
|
| Sex Offenses | 1 | 2021 | 48 | 0.180 |
Why?
|
| Registries | 9 | 2007 | 1397 | 0.180 |
Why?
|
| Focus Groups | 1 | 2020 | 199 | 0.160 |
Why?
|
| Risk-Taking | 2 | 2012 | 92 | 0.160 |
Why?
|
| Program Evaluation | 2 | 2018 | 449 | 0.160 |
Why?
|
| Cost of Illness | 2 | 2013 | 243 | 0.150 |
Why?
|
| Counseling | 2 | 2011 | 219 | 0.150 |
Why?
|
| Survivors | 3 | 2016 | 345 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 225 | 0.150 |
Why?
|
| Longitudinal Studies | 9 | 2007 | 1313 | 0.150 |
Why?
|
| Health Services Needs and Demand | 2 | 2016 | 172 | 0.150 |
Why?
|
| Faculty | 1 | 2018 | 100 | 0.150 |
Why?
|
| Androgen Antagonists | 2 | 2010 | 119 | 0.150 |
Why?
|
| Homosexuality | 2 | 2016 | 18 | 0.140 |
Why?
|
| Body Mass Index | 3 | 2017 | 1551 | 0.140 |
Why?
|
| Personality Inventory | 2 | 2012 | 166 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2020 | 756 | 0.140 |
Why?
|
| Neoplasms | 1 | 2012 | 2759 | 0.140 |
Why?
|
| Tobacco Use | 1 | 2017 | 24 | 0.140 |
Why?
|
| Mentors | 1 | 2018 | 145 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2020 | 519 | 0.140 |
Why?
|
| Reproducibility of Results | 6 | 2012 | 2844 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2021 | 549 | 0.130 |
Why?
|
| Uncertainty | 3 | 2015 | 99 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2013 | 828 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2007 | 865 | 0.130 |
Why?
|
| Leadership | 1 | 2018 | 230 | 0.130 |
Why?
|
| Health Care Costs | 2 | 2011 | 366 | 0.130 |
Why?
|
| Alcoholism | 1 | 2018 | 230 | 0.130 |
Why?
|
| Heterosexuality | 1 | 2016 | 10 | 0.130 |
Why?
|
| Travel | 1 | 2017 | 116 | 0.130 |
Why?
|
| Psychometrics | 4 | 2012 | 666 | 0.130 |
Why?
|
| Veterans Health | 1 | 2017 | 174 | 0.120 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 3382 | 0.120 |
Why?
|
| Object Attachment | 1 | 2015 | 52 | 0.120 |
Why?
|
| Time Factors | 6 | 2017 | 6228 | 0.120 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2016 | 192 | 0.120 |
Why?
|
| Cystoscopy | 1 | 2014 | 44 | 0.120 |
Why?
|
| Stress, Psychological | 3 | 2016 | 556 | 0.120 |
Why?
|
| Proportional Hazards Models | 6 | 2012 | 1305 | 0.120 |
Why?
|
| Internet | 1 | 2017 | 378 | 0.110 |
Why?
|
| Attitude to Health | 3 | 2012 | 260 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2012 | 1390 | 0.110 |
Why?
|
| Disease Management | 2 | 2014 | 516 | 0.110 |
Why?
|
| Libido | 2 | 2010 | 34 | 0.110 |
Why?
|
| Databases, Factual | 3 | 2007 | 1172 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2018 | 626 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2014 | 197 | 0.100 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2012 | 21 | 0.100 |
Why?
|
| Unsafe Sex | 1 | 2012 | 20 | 0.100 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 99 | 0.100 |
Why?
|
| Smoking | 2 | 2014 | 1031 | 0.100 |
Why?
|
| Cisplatin | 1 | 2013 | 242 | 0.100 |
Why?
|
| Self Efficacy | 3 | 2015 | 192 | 0.100 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 110 | 0.100 |
Why?
|
| Documentation | 1 | 2013 | 120 | 0.100 |
Why?
|
| Ureteral Neoplasms | 1 | 2012 | 24 | 0.100 |
Why?
|
| Hospitalization | 3 | 2009 | 1739 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 593 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2018 | 973 | 0.100 |
Why?
|
| Kidney Pelvis | 1 | 2012 | 44 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2014 | 470 | 0.090 |
Why?
|
| Health Promotion | 1 | 2014 | 390 | 0.090 |
Why?
|
| Disease-Free Survival | 4 | 2006 | 859 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2012 | 169 | 0.090 |
Why?
|
| Health Resources | 1 | 2011 | 116 | 0.090 |
Why?
|
| Young Adult | 5 | 2025 | 8871 | 0.090 |
Why?
|
| Mental Health Services | 2 | 2013 | 247 | 0.090 |
Why?
|
| HIV Infections | 3 | 2012 | 1856 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 805 | 0.080 |
Why?
|
| Penile Erection | 1 | 2010 | 74 | 0.080 |
Why?
|
| Health Policy | 2 | 2014 | 213 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 677 | 0.080 |
Why?
|
| Sexuality | 1 | 2009 | 15 | 0.080 |
Why?
|
| Case Management | 1 | 2009 | 21 | 0.080 |
Why?
|
| Private Sector | 1 | 2009 | 24 | 0.080 |
Why?
|
| Family | 1 | 2012 | 571 | 0.080 |
Why?
|
| Psychology | 1 | 2009 | 57 | 0.080 |
Why?
|
| Age Factors | 5 | 2016 | 2805 | 0.080 |
Why?
|
| Group Processes | 1 | 2009 | 47 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2006 | 994 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2013 | 12168 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2015 | 6032 | 0.080 |
Why?
|
| Prognosis | 5 | 2013 | 4515 | 0.080 |
Why?
|
| Medication Adherence | 1 | 2012 | 387 | 0.070 |
Why?
|
| Goals | 1 | 2009 | 128 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2009 | 138 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2009 | 123 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 434 | 0.070 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 6387 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2009 | 383 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2008 | 138 | 0.070 |
Why?
|
| Coitus | 1 | 2006 | 20 | 0.070 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 38 | 0.070 |
Why?
|
| Sex Factors | 3 | 2016 | 1263 | 0.070 |
Why?
|
| Orchiectomy | 1 | 2006 | 49 | 0.070 |
Why?
|
| North America | 1 | 2006 | 239 | 0.060 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2013 | 93 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 280 | 0.060 |
Why?
|
| Lymph Node Excision | 1 | 2006 | 157 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 142 | 0.060 |
Why?
|
| Psychiatry | 1 | 2009 | 263 | 0.060 |
Why?
|
| Complementary Therapies | 1 | 2005 | 41 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2006 | 165 | 0.060 |
Why?
|
| Quadriceps Muscle | 1 | 2025 | 12 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2008 | 4709 | 0.060 |
Why?
|
| Athletic Performance | 1 | 2024 | 9 | 0.060 |
Why?
|
| Prostate | 3 | 2020 | 431 | 0.060 |
Why?
|
| Research Design | 1 | 2009 | 679 | 0.060 |
Why?
|
| Health Services | 1 | 2005 | 71 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2013 | 16066 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1662 | 0.060 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 254 | 0.060 |
Why?
|
| Obesity | 2 | 2006 | 2233 | 0.060 |
Why?
|
| Risk Factors | 8 | 2015 | 10042 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 239 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2025 | 244 | 0.060 |
Why?
|
| Spouses | 2 | 2016 | 66 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 400 | 0.050 |
Why?
|
| Social Values | 1 | 1993 | 47 | 0.050 |
Why?
|
| Length of Stay | 1 | 2009 | 1289 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 1259 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2012 | 770 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2008 | 1415 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 196 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 232 | 0.050 |
Why?
|
| Homeostasis | 1 | 2024 | 683 | 0.040 |
Why?
|
| Texas | 2 | 2021 | 3568 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 714 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 2031 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2012 | 1011 | 0.040 |
Why?
|
| Age Distribution | 1 | 2018 | 410 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1439 | 0.040 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 73 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2013 | 3337 | 0.040 |
Why?
|
| Social Class | 2 | 2008 | 191 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 136 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 1498 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 353 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 213 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 604 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 321 | 0.030 |
Why?
|
| Survival Rate | 2 | 2012 | 2001 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2115 | 0.030 |
Why?
|
| Health Education | 1 | 1996 | 225 | 0.030 |
Why?
|
| California | 2 | 2005 | 127 | 0.030 |
Why?
|
| Biopsy, Needle | 2 | 2005 | 229 | 0.030 |
Why?
|
| Child Abuse, Sexual | 1 | 2013 | 34 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1239 | 0.030 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 52 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2013 | 170 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 28 | 0.020 |
Why?
|
| Infertility | 1 | 2013 | 90 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 229 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2011 | 72 | 0.020 |
Why?
|
| Violence | 1 | 2012 | 115 | 0.020 |
Why?
|
| Emotions | 2 | 2005 | 361 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 368 | 0.020 |
Why?
|
| Feminization | 1 | 2010 | 3 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2012 | 358 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 354 | 0.020 |
Why?
|
| SEER Program | 1 | 2012 | 194 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 295 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 154 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 300 | 0.020 |
Why?
|
| Health Literacy | 1 | 2010 | 79 | 0.020 |
Why?
|
| Informatics | 1 | 2009 | 8 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2009 | 13 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1006 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 218 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Parents | 1 | 1996 | 1033 | 0.020 |
Why?
|
| Asthma | 1 | 1996 | 744 | 0.020 |
Why?
|
| Consensus | 1 | 2011 | 610 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2010 | 177 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 492 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 437 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1801 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2014 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2008 | 74 | 0.020 |
Why?
|
| Income | 1 | 2008 | 133 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2008 | 135 | 0.020 |
Why?
|
| Sex Education | 1 | 2006 | 20 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 88 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 164 | 0.020 |
Why?
|
| Finasteride | 1 | 2006 | 20 | 0.020 |
Why?
|
| Pelvis | 1 | 2006 | 68 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2006 | 142 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 270 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 586 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 90 | 0.020 |
Why?
|
| Life Tables | 1 | 2005 | 29 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 624 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 739 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2005 | 22 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2005 | 96 | 0.020 |
Why?
|
| Urinary Tract | 1 | 2005 | 60 | 0.010 |
Why?
|
| Exercise | 1 | 2010 | 816 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3020 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3052 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1419 | 0.010 |
Why?
|
| Social Behavior | 1 | 2005 | 207 | 0.010 |
Why?
|
| Ejaculation | 1 | 2003 | 20 | 0.010 |
Why?
|
| Sick Role | 1 | 2003 | 31 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 576 | 0.010 |
Why?
|
| Condoms | 1 | 1993 | 48 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 384 | 0.010 |
Why?
|
| Risk | 1 | 2005 | 747 | 0.010 |
Why?
|
| AIDS Serodiagnosis | 1 | 1993 | 56 | 0.010 |
Why?
|
| Penile Prosthesis | 1 | 2003 | 33 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 404 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2006 | 678 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1993 | 116 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2007 | 606 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 470 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 321 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 581 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 570 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 19132 | 0.010 |
Why?
|
| Child | 2 | 2013 | 24264 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1996 | 279 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 1996 | 217 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 33822 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1996 | 1247 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 13916 | 0.000 |
Why?
|